Skip To Main Content
Somlata Khamaru on Muck Rack

Somlata Khamaru

As seen in: Wiley Online Library, BioRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Somlata

Contact Somlata, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Targeting Neuropilin‐1 to Enhance Immunotherapy in Melanoma: Reducing Peripheral Treg‐Mediated Immunosuppression and Tumour Progression

|
By Somlata Khamaru, Kshyama Subhadarsini Tung, Subhasis Chattopadhyay
| Wiley Online Library Verified
Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The original contributions presented in the study are included in the article/. Further inquiries can be directed to the corresponding authors. Supporting Information Filename Description imm70072-sup-0001-FigureS1-S12-TableS1.docxWord 2007 document , 21.5 MB Figure S1: Schematic representation of the experimental set-up for suppression assay of Tregs.
Open in Who Shared Issue with article?

Targeting Neuropilin-1 to Enhance Immunotherapy in Melanoma: Reducing Tumour Progression and Peripheral Treg-Mediated Immunosuppression

|
By Subhasis Chattopadhyay, Somlata Khamaru, Kshyama Subhadarsini Tung
| BioRxiv
Abstract Melanoma, the most aggressive form of skin cancer with a high mutation rate, is the fifth most common cancer among Caucasians. Despite advancements in treatments like immune checkpoint inhibitors and targeted therapies, over 40% of patients experience immune-related adverse events, posing significant challenges.
Open in Who Shared Issue with article?
See all 2 articles